Esophageal diseases

Introduction

At Digestive Disease Week (DDW) this year (3 – 6 May, Chicago, Illinois), investigators gathered from around the world to share discoveries and experience in esophageal diseases. Presentations ranged from advances in endoscopic techniques to noninvasive disease stratification and results from long-term cohort studies. This review discusses results from seven seminal studies in esophageal diseases reported at DDW. Although this work is impressive in its scope and potential for clinical impact, selection of these studies as the “most important” is admittedly somewhat arbitrary, as numerous centers contributed a wealth of new information. With that caveat, below we present our review of the most notable abstracts in esophageal diseases from DDW 2014.

• References

• 1 Dellon ES, Gonsalves N, Hirano I et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 2013; 108: 679-92
• 2 Wolf WA, Jerath MR, Sperry SL et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol In press 2014. [Epub ahead of print]
• 3 Katzka DA, Ravi A, Geno DM et al. Cytosponge evaluation of eosinophilic esophagitis in comparison to endoscopy: accuracy, safety and tolerability. Gastroenterology 2014; 146: 16
• 4 Kadri SR, Lao-Sirieix P, O’Donovan M et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study. BMJ 2010; 341: c4372
• 5 American GastroenterologicalAssociation. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 2011; 140: 1084-1091
• 6 Gross SA, Kaul V, Infantolino A et al. Esophageal brush biopsy with computer-assisted tissue analysis increases detection of Barrett’s esophagus and dysplasia in a multi-site community-based setting. Gastrointest Endosc 2014; 79: AB401
• 7 Gerson LB, Rutenberg M, Scott R. Incremental benefit of computer-assisted brush-biopsy (WATS3D) compared to standard endoscopic biopsy for detection of Barrett’s esophagus (BE) and dysplasia: systematic review and meta-analysis. Gastroenterology 2014; 146: 307
• 8 Wolf WA, Lightdale CJ, Li N et al. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus undergoing radiofrequency ablation (RFA). Gastroenterology 2014; 146: 301-302
• 9 Wani S, Puli SR, Shaheen NJ et al. Esophageal adenocarcinoma in Barrett’s esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 2009; 104: 502-513
• 10 Sikkema M, De Jonge PJ, Steyerberg EW et al. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010; 8: 235-244
• 11 Wolf WA, Pruitt RE, Ertam A et al. Predictors of esophageal adenocarcinoma in patients with prior radiofrequency ablation for treatment of Barrett’s esophagus: results from the U.S. RFA Registry. Gastrointest Endosc 2014; 79: AB217
• 12 Siersema PD, Bredenoord AJ, Conchillo JM et al. Electrical stimulation therapy (EST) of the lower esophageal sphincter (LES) – an effective therapy for refractory GERD – interim results of an international multicenter trial. Gastroenterology 2014; 146: 167
• 13 Limsrivilai J, Charatcharoenwitthaya P, Pausawasdi N et al. Imipramine for treatment of esophageal hypersensitivity and functional heartburn: a randomized double-blind, placebo-controlled trial. Gastroenterology 2014; 146: 165
• 14 Inoue H, Onimaru M, Ikeda H et al. Clinical results of 500 POEM cases for esophageal achalasia and related diseases in a single institute. Gastrointest Endosc 2014; 79: AB165
• 15 Redman JE, Newton R, Malhotra S et al. Biomarkers for early detection of esophageal squamous cell dysplasia and carcinoma. Gastroenterology 2014; 146: 96